Nabil Saba
Vice Chair for Quality and Safety · Emory University School of Medicine
Credentials: · · · ·
History
- 2001–2002
University of Toronto Princess Margaret Hospital
- 1999–2001
- 1997–1999
Princess Margaret Hospital
- 1993–1994
Brigham & Womens Faulkner Hospital
Research
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine · 2016 · 4,100 citations
Review · The Lancet · 2021 · Last of 5 authors · Corresponding · 734 citations
Oral Oncology · 2018 · 640 citations
105 papers
- JB
79 papers
58 papers · 6 as a fellow
- FK
50 papers
45 papers · 2 as a fellow
43 papers
36 papers
35 papers
Grants
- 2019–2032
Winship National Clinical Trials Network Lead Academic Participating Site
National Cancer Institute · UG1
Contact PI · $4.5M · Emory University
- 2023–2029
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients
National Institute on Deafness and Other Communication Disorders · U01
PI · $1.5M · Emory University
- 2014–2018
A Novel Genomics-Based Approach to Differentiate HPV-Positive and -Negative HNC
National Cancer Institute · R21
Contact PI · $373.2K · Emory University
Clinical trials
- 2026–2033
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
- 2023–2026
Principal investigator · Recruiting · Phase 2
Emory University
- 2020–2027
Principal investigator · Active not recruiting · Phase 3
AstraZeneca
- 2019–2027
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)